|
[1]
|
Newman, J.R., Connolly, T.M., Illing, E.A., et al. (2015) Survival Trends in Hypopharyngeal Cancer: A Popula-tion-Based Review. Laryngoscope, 125, 624-629. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hall, S.F., Groome, P.A., Irish, J., et al. (2008) The Natural History of Patients with Squamous Cell Carcinoma of the Hypopharynx. Laryngo-scope, 118, 1362-1371. [Google Scholar] [CrossRef]
|
|
[3]
|
Avinçsal, M.O., Shinomiya, H., Teshima, M., et al. (2018) Impact of Alcohol Dehydrogenase Aldehyde Dehydrogenase Polymorphism on Clinical Out-come in Patients with Hypopharyngeal Cancer. Head & Neck, 40, 770-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Eckel, H.E., Staar, S., Volling, P., et al. (2001) Surgical Treatment for Hy-popharynx Carcinoma: Feasibility Mortality and Results. Otolaryngology—Head and Neck Surgery, 124, 561-569. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lee, J.K., Lee, K.H., Kim, S.A., et al. (2018) p16 as a Prognostic Factor for the Response to Induction Chemotherapy in Advanced Hypopharyngeal Squamous Cell Carcinoma. Oncology Letters, 15, 6571-6577. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chung, E.J., Lee, S.H., Baek, S.H., et al. (2014) Pattern of Cervical Lymph Node Metastasis in Medial Wall Pyriform Sinus Carcinoma. Laryngoscope, 124, 882-887. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kotwall, C.S.K., Razack, M.R.U., Bakamjian, V., et al. (1987) Metastatic Patterns Insquamous Cell Cancer of the Head and Neck. The American Journal of Surgery, 154, 438-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Jager Ea, L.H. and Caldas-Magalhaes, J. (2016) Validated Guidelines for Tumor Delineation on Magnetic Resonance Imaging for Laryngeal and Hypopharyngeal Cancer. Acta Oncologica (Madr), 55, 1305-1312. [Google Scholar] [CrossRef]
|
|
[9]
|
Fukuhara, T., Matsuda, E., Hattori, Y., et al. (2017) Use-fulness of Ultrasound for Assessing the Primary Tumor of Hypopharyngeal Carcinoma. Laryngoscope Investigative Otolaryngology, 2, 390-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Henriques De Figueiredo, B. and Fortpied, C. (2016) Long-Term Update of the 24954 EORTC Phase III Trial on Larynx Preservation. European Journal of Cancer, 65, 109-112. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lefebvre, J.L., Pointreau, Y., et al. (2013) Induction Chemotherapy Followed by either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study. Journal of Clinical Oncology, 31, 853-859. [Google Scholar] [CrossRef]
|
|
[12]
|
Machtay, M., Moughan, J., et al. (2012) Hypopharyngeal Dose Is Associated with Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis. International Journal of Radiation Oncology, Biology, Physics, 84, 983-989. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lefebvre, J.L., Pointreau, Y., Rolland, F., et al. (2013) Induction Chemotherapy Followed by either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study. Journal of Clinical Oncology, 31, 853-859. [Google Scholar] [CrossRef]
|
|
[14]
|
Lefebvre, J.L., Rolland, F., Tesselaar, M., et al. (2009) Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy. JNCI: Journal of the National Cancer Institute, 101, 142-152. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Prades, J.M., Lallemant, B., Garrel, R., et al. (2010) Randomized Phase III Trial Comparing Induction Chemotherapy Followed by Radiotherapy to Concomitant Chemoradiotherapy for Laryngeal Preservation in T3M0 Pyriform Sinus Carcinoma. Acta Oto-Laryngologica, 130, 150-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Posner, M.R., Hershock, D.M., Blajman, C.R., et al. (2007) Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. The New England Journal of Medicine, 357, 1705-1715. [Google Scholar] [CrossRef]
|
|
[17]
|
Masuda, M., Wakasaki, T., Toh, S., et al. (2017) Utility of Chemora-dioselection for the Optimization of Treatment Intensity in Advanced Hypopharyngeal and Laryngeal Carcinoma. Molec-ular and Clinical Oncology, 7, 965-970. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wuthrick, E.J., Zhang, Q., Machtay, M., et al. (2015) Institutional Clinical Trial Accrual Volume and Survival of Patients with Head and Neck Cancer. Journal of Clinical Oncology, 33, 156-164. [Google Scholar] [CrossRef]
|
|
[19]
|
Juloori, A., Koyfman, S.A., Geiger, J.L., et al. (2018) Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and Tox-icity. Anticancer Research, 38, 3543-3549. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lefebvre, J.L. (2009) Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation. Clinical and Experimental Otorhinolaryngology, 2, 159-163. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Durmus, K., Kucur, C., Uysal, I.O., et al. (2015) Feasibility and Clinical Outcomes of Transoral Robotic Surgery and Transoral Robot-Assisted Carbon Dioxide Laser for Hypopharyn-geal Carcinoma. Journal of Craniofacial Surgery, 26, 235-237. [Google Scholar] [CrossRef]
|
|
[22]
|
Lörincz, B.B., Busch, C.J., Möckelmann, N., et al. (2015) Feasibility and Safety of Transoral Robotic Surgery (TORS) for Early Hypopharyngeal Cancer: A Subset Analysis of the Hamburg University TORS-Trial. European Archives of Oto-Rhino-Laryngology, 272, 2993-2998. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Park, Y.M., Kim, W.S., Byeon, H.K., et al. (2010) Feasiblity of Transoral Robotic Hypopharyngectomy for Early-Stage Hypopharyngeal Carcinoma. Oral Oncology, 46, 597-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Dziegielewski, P.T., Kang, S.Y. and Ozer, E. (2015) Transoral Robotic Surgery (TORS) for Laryngeal and Hypopharyngeal Cancers. Journal of Surgical Oncology, 112, 702-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Hanna, E., Sherman, A., Cash, D., et al. (2004) Quality of Life for Patients Following Total Laryngectomy vs Chemoradiation for Laryngeal Preservation. Archives of Otorhinolaryngolo-gy-Head & Neck Surgery, 130, 875-879. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Singer, S., Danker, H., Guntinas-Lichius, O., et al. (2014) Quality of Life before and after Total Laryngectomy: Results of a Multicenter Prospective Cohort Study. Head & Neck, 36, 359-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Ferris, R.L., Blumenschein, G., Fayette, J., et al. (2016) Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. The New England Journal of Medicine, 375, 1856-1867. [Google Scholar] [CrossRef]
|
|
[28]
|
Chow, L.Q.M., Haddad, R., Gupta, S., et al. (2016) Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results from the Phase Ib KEYNOTE-012 Expansion Cohort. Journal of Clinical Oncology, 34, 3838-3845. [Google Scholar] [CrossRef]
|
|
[29]
|
Hasegawa, Y., Goto, M., Hanai, N., et al. (2018) Predictive Bi-omarkers for Combined Chemotherapy with 5-Fluo- rouracil and Cisplatin in Oro- and Hypopharyngeal Cancers. Molec-ular and Clinical Oncology, 8, 378-386. [Google Scholar] [CrossRef] [PubMed]
|